# Alpha Pro Tech Ltd: financial statements, quarterly

APT · NYSE · CIK 884269 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/apt.md) · [Financials](/companies/apt/financials.md) · [Filings](/companies/apt/filings.md) · [Insiders](/companies/apt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/apt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [16.1](/filings/0001437749-24-033866.md) | [15.3 d](/filings/0001437749-25-007218.md) | [13.5](/filings/0001437749-25-015457.md) | [16.3](/filings/0001437749-25-025400.md) | [14.3](/filings/0001437749-25-033545.md) | [13.8 d](/filings/0001437749-26-007797.md) | [13.8](/filings/0001437749-26-015456.md) | [16.7](/filings/0001437749-26-026551.md) | [14.8](/filings/0001437749-25-033545.md) | [13.9 d](/filings/0001437749-26-007797.md) | [14.6](/filings/0001437749-26-015456.md) | [18.7](/filings/0001437749-26-026551.md) |
| Cost of revenue | $m | [10.0](/filings/0001437749-24-033866.md) | [9.6 d](/filings/0001437749-25-007218.md) | [8.1](/filings/0001437749-25-015457.md) | [9.4](/filings/0001437749-25-025400.md) | [8.8](/filings/0001437749-25-033545.md) | [8.6 d](/filings/0001437749-26-007797.md) | [8.4](/filings/0001437749-26-015456.md) | [10.5](/filings/0001437749-26-026551.md) | [8.9](/filings/0001437749-25-033545.md) | [8.7 d](/filings/0001437749-26-007797.md) | [9.1](/filings/0001437749-26-015456.md) | [11.7](/filings/0001437749-26-026551.md) |
| Gross profit | $m | [6.0](/filings/0001437749-24-033866.md) | [5.7 d](/filings/0001437749-25-007218.md) | [5.4](/filings/0001437749-25-015457.md) | [6.8](/filings/0001437749-25-025400.md) | [5.5](/filings/0001437749-25-033545.md) | [5.2 d](/filings/0001437749-26-007797.md) | [5.4](/filings/0001437749-26-015456.md) | [6.1](/filings/0001437749-26-026551.md) | [5.9](/filings/0001437749-25-033545.md) | [5.1 d](/filings/0001437749-26-007797.md) | [5.5](/filings/0001437749-26-015456.md) | [7.0](/filings/0001437749-26-026551.md) |
| Selling, general and administrative | $m | [4.4](/filings/0001437749-24-033866.md) | [4.5 d](/filings/0001437749-25-007218.md) | [4.8](/filings/0001437749-25-015457.md) | [4.9](/filings/0001437749-25-025400.md) | [4.5](/filings/0001437749-25-033545.md) | [4.4 d](/filings/0001437749-26-007797.md) | [4.7](/filings/0001437749-26-015456.md) | [4.6](/filings/0001437749-26-026551.md) | [4.6](/filings/0001437749-25-033545.md) | [4.0 d](/filings/0001437749-26-007797.md) | [4.7](/filings/0001437749-26-015456.md) | [4.7](/filings/0001437749-26-026551.md) |
| Operating income | $m | [1.4](/filings/0001437749-24-033866.md) | [1.0 d](/filings/0001437749-25-007218.md) | [0.3](/filings/0001437749-25-015457.md) | [1.7](/filings/0001437749-25-025400.md) | [0.7](/filings/0001437749-25-033545.md) | [0.7 d](/filings/0001437749-26-007797.md) | [0.5](/filings/0001437749-26-015456.md) | [1.3](/filings/0001437749-26-026551.md) | [1.1](/filings/0001437749-25-033545.md) | [1.0 d](/filings/0001437749-26-007797.md) | [0.6](/filings/0001437749-26-015456.md) | [2.0](/filings/0001437749-26-026551.md) |
| Income tax | $m | [0.4](/filings/0001437749-24-033866.md) | [0.3 d](/filings/0001437749-25-007218.md) | [0.1](/filings/0001437749-25-015457.md) | [0.5](/filings/0001437749-25-025400.md) | [0.2](/filings/0001437749-25-033545.md) | [0.2 d](/filings/0001437749-26-007797.md) | [0.2](/filings/0001437749-26-015456.md) | [0.4](/filings/0001437749-26-026551.md) | [0.3](/filings/0001437749-25-033545.md) | [0.3 d](/filings/0001437749-26-007797.md) | [0.2](/filings/0001437749-26-015456.md) | [0.6](/filings/0001437749-26-026551.md) |
| Net income | $m | [1.4](/filings/0001437749-24-033866.md) | [1.1 d](/filings/0001437749-25-007218.md) | [0.6](/filings/0001437749-25-033545.md) | [1.6](/filings/0001437749-25-033545.md) | [0.9](/filings/0001437749-25-033545.md) | [0.8 d](/filings/0001437749-26-007797.md) | [0.6](/filings/0001437749-26-026551.md) | [1.2](/filings/0001437749-26-026551.md) | [1.0](/filings/0001437749-25-033545.md) | [0.7 d](/filings/0001437749-26-007797.md) | [0.7](/filings/0001437749-26-026551.md) | [1.8](/filings/0001437749-26-026551.md) |
| Diluted EPS | $ per share | [0.12](/filings/0001437749-24-033866.md) | not reported | [0.05](/filings/0001437749-25-015457.md) | [0.15](/filings/0001437749-25-025400.md) | [0.08](/filings/0001437749-25-033545.md) | not reported | [0.06](/filings/0001437749-26-015456.md) | [0.12](/filings/0001437749-26-026551.md) | [0.09](/filings/0001437749-25-033545.md) | not reported | [0.07](/filings/0001437749-26-015456.md) | [0.18](/filings/0001437749-26-026551.md) |
| Basic EPS | $ per share | [0.12](/filings/0001437749-24-033866.md) | not reported | [0.05](/filings/0001437749-25-015457.md) | [0.15](/filings/0001437749-25-025400.md) | [0.08](/filings/0001437749-25-033545.md) | not reported | [0.06](/filings/0001437749-26-015456.md) | [0.12](/filings/0001437749-26-026551.md) | [0.09](/filings/0001437749-25-033545.md) | not reported | [0.07](/filings/0001437749-26-015456.md) | [0.18](/filings/0001437749-26-026551.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [18.2](/filings/0001437749-23-030902.md) | [20.4](/filings/0001437749-25-007218.md) | [18.5](/filings/0001437749-24-015624.md) | [16.2](/filings/0001437749-24-025421.md) | [18.4](/filings/0001437749-24-033866.md) | [18.6](/filings/0001437749-26-007797.md) | [13.4](/filings/0001437749-25-015457.md) | [14.5](/filings/0001437749-25-025400.md) | [17.7](/filings/0001437749-25-033545.md) | [17.0](/filings/0001437749-26-026551.md) | [16.9](/filings/0001437749-26-015456.md) | [18.9](/filings/0001437749-26-026551.md) |
| Current assets | $m | [52.7](/filings/0001437749-23-030902.md) | [53.1](/filings/0001437749-25-007218.md) | [52.4](/filings/0001437749-24-015624.md) | [52.6](/filings/0001437749-24-025421.md) | [51.4](/filings/0001437749-24-033866.md) | [50.6](/filings/0001437749-26-007797.md) | [49.3](/filings/0001437749-25-015457.md) | [50.5](/filings/0001437749-25-025400.md) | [51.7](/filings/0001437749-25-033545.md) | [52.5](/filings/0001437749-26-026551.md) | [51.9](/filings/0001437749-26-015456.md) | [54.2](/filings/0001437749-26-026551.md) |
| Total assets | $m | [64.6](/filings/0001437749-23-030902.md) | [68.8](/filings/0001437749-25-007218.md) | [72.7](/filings/0001437749-24-015624.md) | [72.7](/filings/0001437749-24-025421.md) | [73.3](/filings/0001437749-24-033866.md) | [73.7](/filings/0001437749-26-007797.md) | [72.2](/filings/0001437749-25-015457.md) | [73.2](/filings/0001437749-25-025400.md) | [73.9](/filings/0001437749-25-033545.md) | [74.1](/filings/0001437749-26-026551.md) | [73.0](/filings/0001437749-26-015456.md) | [75.3](/filings/0001437749-26-026551.md) |
| Current liabilities | $m | [2.0](/filings/0001437749-23-030902.md) | [2.6](/filings/0001437749-25-007218.md) | [2.1](/filings/0001437749-24-015624.md) | [1.9](/filings/0001437749-24-025421.md) | [2.7](/filings/0001437749-24-033866.md) | [3.1](/filings/0001437749-26-007797.md) | [2.3](/filings/0001437749-25-015457.md) | [3.0](/filings/0001437749-25-025400.md) | [3.7](/filings/0001437749-25-033545.md) | [4.1](/filings/0001437749-26-026551.md) | [2.6](/filings/0001437749-26-015456.md) | [3.2](/filings/0001437749-26-026551.md) |
| Total liabilities | $m | [3.2](/filings/0001437749-23-030902.md) | [7.2](/filings/0001437749-25-007218.md) | [11.1](/filings/0001437749-24-015624.md) | [10.6](/filings/0001437749-24-025421.md) | [11.3](/filings/0001437749-24-033866.md) | [11.5](/filings/0001437749-26-007797.md) | [10.5](/filings/0001437749-25-015457.md) | [10.9](/filings/0001437749-25-025400.md) | [11.3](/filings/0001437749-25-033545.md) | [11.7](/filings/0001437749-26-026551.md) | [10.0](/filings/0001437749-26-015456.md) | [10.4](/filings/0001437749-26-026551.md) |
| Shareholders' equity | $m | [61.4](/filings/0001437749-24-033866.md) | [61.6](/filings/0001437749-26-007797.md) | [61.6](/filings/0001437749-25-033545.md) | [62.0](/filings/0001437749-25-033545.md) | [62.1](/filings/0001437749-25-033545.md) | [62.2](/filings/0001437749-26-026551.md) | [61.7](/filings/0001437749-26-026551.md) | [62.2](/filings/0001437749-26-026551.md) | [62.5](/filings/0001437749-25-033545.md) | [62.5](/filings/0001437749-26-026551.md) | [63.0](/filings/0001437749-26-026551.md) | [64.9](/filings/0001437749-26-026551.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [3,942 d](/filings/0001437749-24-033866.md) | [3,529 d](/filings/0001437749-25-007218.md) | [(1,169)](/filings/0001437749-25-015457.md) | [(873) d](/filings/0001437749-25-025400.md) | [5,327 d](/filings/0001437749-25-033545.md) | [2,413 d](/filings/0001437749-26-007797.md) | [(3,959)](/filings/0001437749-26-015456.md) | [2,088 d](/filings/0001437749-26-026551.md) | [3,923 d](/filings/0001437749-25-033545.md) | [318 d](/filings/0001437749-26-007797.md) | [12.0](/filings/0001437749-26-015456.md) | [2,213 d](/filings/0001437749-26-026551.md) |
| Capital expenditure | $k | [97.0 d](/filings/0001437749-24-033866.md) | [305 d](/filings/0001437749-25-007218.md) | [83.0](/filings/0001437749-25-015457.md) | [133 d](/filings/0001437749-25-025400.md) | [2,147 d](/filings/0001437749-25-033545.md) | [1,443 d](/filings/0001437749-26-007797.md) | [135](/filings/0001437749-26-015456.md) | [138 d](/filings/0001437749-26-026551.md) | [99.0 d](/filings/0001437749-25-033545.md) | [267 d](/filings/0001437749-26-007797.md) | [117](/filings/0001437749-26-015456.md) | [142 d](/filings/0001437749-26-026551.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | [1,049](/filings/0001437749-24-033866.md) | [1,023 d](/filings/0001437749-25-007218.md) | [1,417](/filings/0001437749-25-015457.md) | [1,284](/filings/0001437749-25-025400.md) | [1,030](/filings/0001437749-25-033545.md) | [721 d](/filings/0001437749-26-007797.md) | [1,178](/filings/0001437749-26-015456.md) | [830](/filings/0001437749-26-026551.md) | [624](/filings/0001437749-25-033545.md) | [713 d](/filings/0001437749-26-007797.md) | [0.0](/filings/0001437749-26-015456.md) | [99.0](/filings/0001437749-26-026551.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.7](/filings/0001437749-23-030902.md) | [12.2](/filings/0001437749-24-015624.md) | [12.0](/filings/0001437749-24-025421.md) | [11.8](/filings/0001437749-24-033866.md) | [11.4](/filings/0001437749-25-015457.md) | [11.2](/filings/0001437749-25-025400.md) | [11.2](/filings/0001437749-25-033545.md) | [10.8](/filings/0001437749-26-015456.md) | [10.6](/filings/0001437749-26-026551.md) | [10.5](/filings/0001437749-25-033545.md) | [10.3](/filings/0001437749-26-015456.md) | [10.3](/filings/0001437749-26-026551.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,206,218 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0001437749-26-026551.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.